| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | — | -33.6% |
| Cost of Revenue | $1.8M | — | -15.5% |
| Gross Profit | $982K | — | -52.4% |
| R&D Expense | $8.8M | — | -22.4% |
| SG&A Expense | $9.4M | — | -17.6% |
| Operating Income | -$17.3M | — | +16.8% |
| Pre-tax Income | -$16.8M | — | +15.2% |
| Income Tax | $10K | — | -90.1% |
| Net Income | -$16.8M | — | +15.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.3M | +0.1% | -9.8% |
| Inventory | $8.1M | +3.6% | +14.3% |
| Current Assets | $181.6M | -9.9% | -28.9% |
| Total Assets | $272.1M | -8.1% | -21.6% |
| Current Liabilities | $10.2M | -34.7% | -22.4% |
| Total Liabilities | $30.7M | -16.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.4M | — | -35.2% |
| Capital Expenditures | $270K | — | -58.7% |
| Investing Cash Flow | $18.1M | — | -26.6% |
| Financing Cash Flow | -$2.6M | — | -73.6% |
| Free Cash Flow | -$15.7M | — | -30.1% |
| -15.5% |
| Stockholders' Equity | $241.5M | -6.9% | -22.4% |